{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:29:11Z","timestamp":1694719751534},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T00:00:00Z","timestamp":1369094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s12032-013-0609-5","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T08:38:17Z","timestamp":1369039097000},"source":"Crossref","is-referenced-by-count":3,"title":["Arrhythmias during and after zoledronic acid infusion patients with bone metastasis"],"prefix":"10.1007","volume":"30","author":[{"given":"Ozan","family":"Yazici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sercan","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozgul","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mevlut","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali Nahit","family":"Sendur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zafer","family":"Arik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebnem","family":"Yaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulay","family":"Eren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dogan","family":"Uncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurullah","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"609_CR1","first-page":"2394","volume":"9","author":"A Ibrahim","year":"2003","unstructured":"Ibrahim A, Scher N, Williams G, et al. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases. Clin Cancer Res. 2003;9:2394\u20139.","journal-title":"Clin Cancer Res"},{"key":"609_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2796.2008.02065.x","volume":"265","author":"B Abrahamsen","year":"2009","unstructured":"Abrahamsen B, Eiken P, Brixen K. Atrial fibrillation in fracture patients treated with oral bisphosphonates. J Intern Med. 2009;265:581\u201392.","journal-title":"J Intern Med"},{"key":"609_CR3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/archinte.168.8.826","volume":"168","author":"SR Heckbert","year":"2008","unstructured":"Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med. 2008;168:826\u201331.","journal-title":"Arch Intern Med"},{"key":"609_CR4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356:1809\u201322.","journal-title":"N Engl J Med"},{"key":"609_CR5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.39507.551644.BE","volume":"336","author":"HT Sorensen","year":"2008","unstructured":"Sorensen HT, Christensen S, Mehnert F, et al. Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ. 2008;336:813\u20136.","journal-title":"BMJ"},{"key":"609_CR6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.amjcard.2008.11.037","volume":"103","author":"TJ Bunch","year":"2009","unstructured":"Bunch TJ, Anderson JL, May HT, et al. Relation of bisphosphonate therapies and risk of developing atrial fibrillation. Am J Cardiol. 2009;103:824\u20138.","journal-title":"Am J Cardiol"},{"key":"609_CR7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/bjc.2011.338","volume":"105","author":"R Erichsen","year":"2011","unstructured":"Erichsen R, Christiansen CF, Fr\u00f8slev T, Jacobsen J, S\u00f8rensen HT. Intravenous bisphosphonate therapy and atrial fibrillation\/flutter risk in cancer patients: a nationwide cohort study. Br J Cancer. 2011;105:881\u20133.","journal-title":"Br J Cancer"},{"key":"609_CR8","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1200\/JCO.2010.28.7524","volume":"28","author":"GS Wilkinson","year":"2010","unstructured":"Wilkinson GS, Baillargeon J, Kuo YF, Freeman JL, Goodwin JS. Atrial fibrillation and stroke associated with intravenous bisphosphonate therapy in older patients with cancer. J Clin Oncol. 2010;28:4898\u2013905.","journal-title":"J Clin Oncol"},{"key":"609_CR9","doi-asserted-by":"crossref","first-page":"e4720","DOI":"10.1371\/journal.pone.0004720","volume":"4","author":"A Grosso","year":"2009","unstructured":"Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L. Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self controlled case-series safety analysis. PLoS ONE. 2009;4:e4720.","journal-title":"PLoS ONE"},{"key":"609_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","volume":"126","author":"M McClung","year":"2013","unstructured":"McClung M, Harris ST, Miller PD, et al. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med. 2013;126:13\u201320.","journal-title":"Am J Med"},{"key":"609_CR11","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","volume":"357","author":"KW Lyles","year":"2007","unstructured":"Lyles KW, Col\u00f3n-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357:1799\u2013809.","journal-title":"N Engl J Med"},{"key":"609_CR12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00520-010-0868-z","volume":"19","author":"C Arslan","year":"2011","unstructured":"Arslan C, Aksoy S, Dizdar O, Dede DS, Harputluoglu H, Altundag K. Zoledronic acid and atrial fibrillation in cancer patients. Support Care Cancer. 2011;19:425\u201330.","journal-title":"Support Care Cancer"},{"key":"609_CR13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00002018-200932030-00004","volume":"32","author":"YK Loke","year":"2009","unstructured":"Loke YK, Jeevanantham V, Singh S. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis. Drug Saf. 2009;32:219\u201328.","journal-title":"Drug Saf"},{"key":"609_CR14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.RES.58.4.495","volume":"58","author":"LH Frame","year":"1986","unstructured":"Frame LH, Page RL, Hoffman BF. Atrial reentry around an anatomic barrier with a partially refractory excitable gap. a canine model of atrial flutter. Circ Res. 1986;58:495\u2013511.","journal-title":"Circ Res"},{"key":"609_CR15","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/01.CIR.96.6.2048","volume":"96","author":"K Kamjoo","year":"1997","unstructured":"Kamjoo K, Uchida T, Ikeda T, et al. Importance of location and timing of electrical stimuli in terminating sustained functional reentry in isolated swine ventricular tissues: evidence in support of a small reentrant circuit. Circulation. 1997;96:2048\u201360.","journal-title":"Circulation"},{"key":"609_CR16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccep.2010.10.012","volume":"3","author":"C Antzelevitch","year":"2011","unstructured":"Antzelevitch C, Burashnikov A. Overview of basic mechanisms of cardiac arrhythmia. Card Electrophysiol Clin. 2011;3:23\u201345.","journal-title":"Card Electrophysiol Clin"},{"key":"609_CR17","doi-asserted-by":"crossref","first-page":"53J","DOI":"10.1016\/0002-9149(89)91200-9","volume":"64","author":"FC Messineo","year":"1989","unstructured":"Messineo FC. Ventricular ectopic activity: prevalence and risk. Am J Cardiol. 1989;64:53J\u20136J.","journal-title":"Am J Cardiol"},{"key":"609_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0033-0620(77)90005-6","volume":"19","author":"JT Bigger Jr","year":"1977","unstructured":"Bigger JT Jr, Dresdale FJ, Heissenbuttel RH, Weld FM, Wit AL. Ventricular arrhythmias in ischemic heart disease: mechanism, prevalence, significance, and management. Prog Cardiovasc Dis. 1977;19:255.","journal-title":"Prog Cardiovasc Dis"},{"key":"609_CR19","first-page":"1131","volume-title":"Cardiac arrhythmia: mechanisms, diagnosis, and management","author":"RJ Kantor","year":"1995","unstructured":"Kantor RJ, Garson A. Arrhythmias in congenital heart disease. In: Podrid PJ, Kowey PR, editors. Cardiac arrhythmia: mechanisms, diagnosis, and management. Baltimore: Williams & Wilkins; 1995. p. 1131."},{"key":"609_CR20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","volume":"271","author":"EJ Benjamin","year":"1994","unstructured":"Benjamin EJ, Levy D, Vaziri SM, D\u2019Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort the Framingham Heart Study. JAMA. 1994;271:840\u20134.","journal-title":"JAMA"},{"key":"609_CR21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/europace\/eur364","volume":"14","author":"J Zhuang","year":"2012","unstructured":"Zhuang J, Wang Y, Tang K, et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace. 2012;14:638\u201345.","journal-title":"Europace"},{"key":"609_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijcard.2007.12.078","volume":"128","author":"M Lainscak","year":"2008","unstructured":"Lainscak M, Dagres N, Filippatos GS, Anker SD, Kremastinos DT. Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol. 2008;128:311\u20135.","journal-title":"Int J Cardiol"},{"key":"609_CR23","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","volume":"60","author":"Y Guo","year":"2012","unstructured":"Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60:2263\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"609_CR24","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1253\/circj.CJ-12-1099","volume":"76","author":"N Takahashi","year":"2012","unstructured":"Takahashi N, Kume O, Wakisaka O, et al. Novel strategy to prevent atrial fibrosis and fibrillation. Circ J. 2012;76:2318\u201326.","journal-title":"Circ J"},{"key":"609_CR25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5543\/tkda.2012.64160","volume":"40","author":"S K\u00f6ro\u011flu","year":"2012","unstructured":"K\u00f6ro\u011flu S, Tuncer C, Acar G. Relation of inflammatory and oxidative markers to the occurrence and recurrence of persistent atrial fibrillation. Turk Kardiyol Dern Ars. 2012;40:499\u2013504.","journal-title":"Turk Kardiyol Dern Ars"},{"key":"609_CR26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1211\/jpp.60.8.0015","volume":"60","author":"RH Du","year":"2008","unstructured":"Du RH, Yi HW, Dai DZ, Tang WH, Dai Y. Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent. J Pharm Pharmacol. 2008;60:1089\u201395.","journal-title":"J Pharm Pharmacol"},{"key":"609_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jbspin.2006.06.005","volume":"74","author":"A Corrado","year":"2007","unstructured":"Corrado A, Santoro N, Cantatore FP. Extra-skeletal effects of bisphosphonates. Joint Bone Spine. 2007;74:32\u20138.","journal-title":"Joint Bone Spine"},{"key":"609_CR28","first-page":"1165","volume":"91","author":"AM Wolf","year":"2006","unstructured":"Wolf AM, Rumpold H, Tilg H, Gastl G, Gunsilius E, Wolf D. The effect of zoledronic acid on the function and differentiation of myeloid cells. Haematologica. 2006;91:1165\u201371.","journal-title":"Haematologica"},{"key":"609_CR29","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1002\/jcb.23267","volume":"112","author":"EL Scheller","year":"2011","unstructured":"Scheller EL, Hankenson KD, Reuben JS, Krebsbach PH. Zoledronic acid inhibits macrophage SOCS3 expression and enhances cytokine production. J Cell Biochem. 2011;112:3364\u201372.","journal-title":"J Cell Biochem"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0609-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0609-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0609-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:22:22Z","timestamp":1559427742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0609-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0609-5","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,21]]},"article-number":"609"}}